Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients

被引：0
作者：
Chen, Nai-Yu [1 ]
Chiu, Yung-Ting [1 ]
Chuang, Chiao-Hsiung [2 ]
Chang, Yu-Ching [3 ]
Cheng, Ching-Lan [1 ]
机构：
[1] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Dept Internal Med, Med Coll & Hosp, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
816
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
[41]   Effect of anti-TNFα therapy with daily physical activity in patients with Crohn's disease [J].
Lucca, F. A. ;
Malaguti, C. ;
Cabalzar, A. L. ;
Chebli, L. A. ;
Ribeiro, T. C. R. ;
Gaburri, P. D. ;
Chebli, J. M. F. .
JOURNAL OF CROHNS & COLITIS, 2016, 10 :S344-S344
[42]   Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study [J].
Cassandra, Rayer ;
Nachury, Maria ;
Arnaud, Bourreille ;
Xavier, Roblin ;
Laurent, Peyrin-Biroulet ;
Stephanie, Viennot ;
Mathurin, Flamant ;
David, Laharie ;
Benedicte, Caron ;
Marie, Dewitte ;
Laurent, Siproudhis ;
Mathurin, Fumery ;
Guillaume, Bouguen .
BMC GASTROENTEROLOGY, 2022, 22 (01)
[43]   The role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease [J].
Mascheretti, S ;
Schreiber, S .
PHARMACOGENOMICS, 2004, 5 (05) :479-486
[44]   Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease [J].
Aggarwal, Divya ;
Limdi, Jimmy K. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) :13-19
[45]   Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy [J].
Franco Leal, Raquel ;
Planell, Nuria ;
Kajekar, Radhika ;
Lozano, Juan J. ;
Ordas, Ingrid ;
Dotti, Isabella ;
Esteller, Miriam ;
Carme Masamunt, M. ;
Parmar, Harsukh ;
Ricart, Elena ;
Panes, Julian ;
Salas, Azucena .
GUT, 2015, 64 (02) :233-242
[46]   WEIGHT ADJUSTED ANTI-TNF THERAPY FAVOURS OBESE PATIENTS WITH CROHN'S DISEASE [J].
Bhalme, M. ;
Sharma, A. ;
Keld, R. ;
Makin, A. ;
Willert, R. ;
Campbell, S. .
GUT, 2012, 61 :A228-A228
[47]   Use of Anti-TNF Therapy in Patients With Crohn's Disease Complicated by an Abdominal Phlegmon [J].
O'Donnell, Sarah ;
Chawla, Tanya P. ;
Nguyen, Geoffrey C. ;
Silverberg, Mark S. ;
Steinhart, A. Hillary ;
Croitoru, Kenneth .
GASTROENTEROLOGY, 2015, 148 (04) :S459-S459
[48]   ANTI-TNF THERAPY REDUCES IONISING RADIATION EXPOSURE IN PATIENTS WITH CROHN'S DISEASE [J].
Aggarwal, D. ;
Limdi, J. K. .
GUT, 2014, 63 :A79-A79
[49]   Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus [J].
Gonzalez-Lama, Yago ;
Ricart, Elena ;
Carpio, Daniel ;
Bastida, Guillermo ;
Ceballos, Daniel ;
Ginard, Daniel ;
Marin-Jimenez, Ignacio ;
Menchen, Luis ;
Munoz, Fernando .
BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01)
[50]   Anti-TNF therapy use in pregnant patients with Crohn's disease and ulcerative colitis [J].
Kiely, C. ;
Subramaniam, K. ;
Pavli, P. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 :104-104
12345